Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy eases chronic back and leg pain in small study

NCT ID NCT07305792

Symptom relief Sponsor: October 6 University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether High Tone Power Therapy can help people with long-term lower back pain that travels down one leg. 52 adults aged 35 to 50 with a herniated disc took part. The therapy aims to reduce pain, improve movement, and boost quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Dec 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Their ages range from 35 to 50 years. * Both sex. * Back pain for more than six months; radiating unilaterally down to one lower limb over the dermatomal distributions of L4-L5, L5-S1 nerve roots. * Radiological confirmation of disc herniation or protrusion at L4-5 or L5-S1 levels by MRI. * Symptom duration of at least 4 weeks and not more than 6 months. * Positive Straight Leg Raise test * Body mass index (18.5 - 24.99Kg/m2). Exclusion criteria * Red flags: spinal tumors, cauda equina syndrome, spinal fractures, osteoporosis, infection. * Bilateral symptoms. * Spondylolisthesis, spondylitis, spinal canal stenosis. * Previous lumbopelvic or hip surgery or injection. * Any hip structural abnormality such as malformations, impingements and degeneration. * Postural deviations such as scoliosis, kyphosis and lateral shift. * Fibromyalgia. * Pregnancy and Gynecological problems. * Systemic inflammatory conditions (e.g., rheumatoid arthritis and ankylosing spondylitis) * Uncontrolled chronic conditions (e.g., diabetes mellitus with neuropathy and severe cardiovascular disease)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Radiculopathy lumbar are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

radiculopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Radiculopathy lumbar

Contacts and locations

Locations

  • October 6 University

    Giza, El-Sheikh Zayed City Giza 1133 Egypt, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.